By Vincent Mumo Nzilani LONDON/NAIROBI, July 21 (Reuters) - Around 77,000 fewer children worldwide received HIV treatment ...

GILD's HIV franchise gains momentum with strong Biktarvy and Descovy demand, Yeztugo growth and a promising pipeline targeting long-term expansion.

UNAIDS chief calls for ‘radical change’ as aid cuts gut HIV clinics and treatment worldwide.

If approved, ISL/LEN could become the first once-weekly, single-tablet HIV treatment to reach the market as patients rely on ...

The Trump administration's cuts to the U.S. Agency for International Development and thousands of global health grants have ...

– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV eradication cure scenarios could consistently reduce new HIV infections among ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

A Q&A With Rajesh Gandhi, MD. GANDHI: The main reasons patients and their clinicians consider switching are to simplify treatment, reduce drug interactions, and mitigate long-term safety risks. In my ...

Researchers say they’ve taken a major step toward finding a cure for HIV. As The Guardian reports, scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne found a way to make ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment ...

A new report says the Trump administration’s disruptions to a global AIDS relief program have forced organizations to close ...